Company Milestone
time line
About Us | Company Milestone 3802 Views 2020-04-14 09:59
In November, PersonGen received capital investment from Anhui Anke Biotechnology (Group) Co., Ltd.
In November, PersonGen launched the world's first clinical trial of a MUC1-CAR-T cell products for solid tumors.
In July, PersonGen won the Advanced Technology Service Enterprise.
In March, PersonGen launched the world's first clinical trial of a multi-target CAR-NK cell product.